Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMSRAMRCGP

Multimorbidity

Essential points for quick revision.

Saved on this device

Synopsis

Prioritise person-centred care for adults with multiple long-term conditions by reducing treatment burden, reconciling competing recommendations and agreeing outcomes that matter to the individual.

  • Multimorbidity means two or more long-term conditions; combinations of physical and mental illness, frailty, pain, sensory loss and substance dependence may interact clinically and socially.
  • Consider a tailored multimorbidity approach when care is fragmented, treatment burden is high, medicines create risk, function is declining or the person struggles to follow multiple single-disease plans.
  • Start with the person’s goals, current symptoms, function, mental health, social context and treatment workload before optimising individual biomarkers.

Reasoning priorities

01
Goals and function assessment

Define the outcomes the person values and current capability.

Translate priorities into measurable daily outcomes rather than assuming disease targets are the primary goal.

Worked reasoning

Worked case: dizziness and a crowded regimenPrioritise benefit, harm and burden

An 82-year-old with five long-term conditions, twelve medicines and recent falls wants to stay independent but feels dizzy after morning tablets.

  1. Assess postural symptoms, falls injury, hydration, cognition, mood, function, adherence, support and urgent causes; reconcile every medicine with indication, timing and prescriber.
  2. Map competing benefits and harms, including blood-pressure lowering, sedative or anticholinergic load, renal function, fracture risk and the patient’s priority of safe walking.
  3. Agree a final coordinated plan that addresses immediate fall risk, changes the most plausible harmful treatment with the responsible prescriber, simplifies timing and preserves clearly valuable symptom or secondary-prevention therapy.
  4. Verify with lying and standing observations or other indicated monitoring, a defined symptom and falls review, written ownership, pharmacist communication and a contingency if symptoms or disease control worsen.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom